Brown Brothers Harriman & Co’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-7,599
Closed -$195K – 1899
2025
Q3
$195K Hold
7,599
– – ﹤0.01% 698
2025
Q2
$192K Buy
+7,599
New +$189K ﹤0.01% 638

Other funds holding IBDX

Brown Brothers Harriman & Co's IBDX Position: Q4 2025 in Review

Brown Brothers Harriman & Co sold out of iShares iBonds Dec 2032 Term Corporate ETF (IBDX) in Q4 2025, closing a stake of 7,599 shares — an estimated $195K sold.

Brown Brothers Harriman & Co first reported a position in IBDX in Q2 2025 and held it in 2 quarters. The position peaked at $195K in Q3 2025. 198 funds tracked by Wall St. Rank hold IBDX as of Q4 2025.

  • Brown Brothers Harriman & Co reported no remaining iShares iBonds Dec 2032 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 7,599 iShares iBonds Dec 2032 Term Corporate ETF shares in Q4 2025, an estimated $195K.
  • Brown Brothers Harriman & Co first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q2 2025 and held it in 2 quarters.
  • Brown Brothers Harriman & Co's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $195K in Q3 2025.
  • 198 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q4 2025.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2025, filed 12 Feb 2026.